Clinical value of tranexamic acid for blood loss in unilateral and bilateral TKAs
Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trialKnee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1870-8
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
180 unilateral and 150 bilateral total knee arthroplasty (TKA) patients were randomly allocated into either a tranexamic acid (TXA) group or a control group. There were similar trends found in both unilateral and bilateral TKA groups treated with TXA, in regards to reducing total blood loss, blood loss via the drain, and haemoglobin drop. However, only TXA patients that had undergone bilateral TKA...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue